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ABSTRACT
The tumor marker carcinoembryonic antigen (CEA) is predominantly
expressed in epithelial cells along the gastreintestinal tract and in a variety
ofadenocarcinomas. As a basis for investigating its in vivo regulation and
for establishing an animal model for tumor immunotherapy, transgenic
mice were generated with a 33-kilobase cosmid clone insert containing the
complete human CEA gene and flanking sequences. CEA was found in the
tongue, esophagus, stomach, small Intestine, cecum, colon, and trachea
and at low levels in the lung, testis, and uterus ofadult mice of independ
ent transgenic strain& CEA was first detected at day 10.5 of embryonic
development (embryonic day 10.5) In primary trophoblast giant cells and
was found in the developing gut, urethra, trachea, lung, and nucleus
pulposus of the vertebral column from embryonic day 14.5 onwards.
From embryonic day 16,5 CPA was also visible in the nasal mucosa and
tongue. Because this spatiotemporal expression pattern correlates well
with that known for humans, it follows that the transferred genomic
region contains all of the regulatory elements required for the correct
expression of CEA. Furthermore, although mice apparently lack an en
dogenous CEA gene, the entire repertoire of transcription factors neces
sary for correct expression of the CEA transgene is conserved between
mice and humans. After tumor induction, these immunocompetent mice
will serve as a model for optimizing various forms of immunotherapy,
using CEA as a target antigen.
INTRODUCTION
CEA4 is a well known tumor marker for a variety of adenocarci
nomas, especially colorectal tumors. Despite its presence in certain
normal tissues, increased serum concentrations have made it a useful
indicater of residual disease or tumor recurrences in the postoperative
surveillance of tumor patients following resection (1). Because CEA
is located in the plasma membrane of tumor cells, it can also be used
for targeting CEA-specific mAb in the radio-immunobocalization or
immunotherapy of CEA-expressing tumors and their metastases (2,
3). However, a number of problems exist that still limit the usage of
CEA for tumor targeting. These include antibody penetration of
tumors, liver and kidney uptake of antibodies, and antibody binding to
normal tissues that express CEA, which could lead to autoimmune
responses or tissue destruction through cytotoxic antibody conjugates
(2).
Molecular cloning has revealed that CEA belongs to a gene family
consisting of at least 22 genes (4) which are part of the immunoglob
ulin gene superfamily. Sequence comparisons identify two main sub
groups. The CEA subgroup members are mainly membrane bound,
either as integral membrane proteins, e.g., BGP, or after post-trans
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lational modification, via a glycosyl phosphatidylinositol moiety, as
found for CEA (5). In vitro, CEA subgroup members convey homo
and heterophilic cell adhesion (6, 7). The second subgroup consists of
11 genes encoding the secreted pregnancy-specific glycoproteins of
unknown function. CEA gene families have also been characterized in
rodents (8â€”10).Despite homology, it has proven difficult to determine
rodent counterparts for individual human genes through sequence
comparisons. Surprisingly, no CE4 homologue has thus far been
identified; in fact, no rodent CEA-related molecules containing a
glycosyl phosphatidylinositol anchor have been characterized to date.
CEA family members in normal tissues show distinct expression
patterns (5). Immunohistochemistry has revealed that CEA is mainly
restricted to distinct regions of the gastrointestinal tract (1 1). Various
other members of the CEA subgroup, e.g., nonspecific cross-reacting
antigen and BGP, are often coexpressed with CEA in the colonic
mucosa. However, nonspecific cross-reacting antigen and BGP are
also found in maturing granulocytes that do not express CEA (5, 12).
In addition, BGP is expressed in epithelia of bile canaliculi (5).
Pregnancy-specific glycoprotein subgroup members are synthesized
mainly in the syncytiotrophoblast cells of the placenta (13).
In an attempt to determine the elements responsible for regulating
the expression of CEA at the transcriptional level, we previously
described the isolation of a cosmid clone containing the complete
coding region of the CEA gene, including 3.3 kilobases of the 5'-
flanking region and 5 kilobases of the 3'-flanking region (14). After
stable transfection of Chinese hamster ovary cells with this cosmid
clone, membrane-bound CEA was expressed under the control of its
own cis-regulatory elements, which were recognized by the rodent
trans-acting factors (15). Functional analyses in a transient transfec
tion assay allowed identification of a 424-base pair region, upstream
from the translational start site, that apparently allows cell type
specific expression of the CEA gene (14).
In this communication, we have used the complete insert of the
same CEA cosmid clone to generate transgenic mice that stably
express human CEA. These studies present a basis for identification of
the elements responsible for regulating the spatiotemporal expression
pattern of CEA in vivo, both during fetal development and in adult
mice. Additionally, the CEA promoter may be useful in directing the
expression of different oncogenes to epithelial cells so that their roles
in tumorigenesis of organs belonging to the gastrointestinal tract may
be better understood. Finally, after induction of tumors in CEA
transgenic mice, the usefulness and possible unwanted side effects of
CEA as a target antigen for immunotherapy of CEA-producing tumors
can be investigated in these immunocompetent mice.
MATERIALS AND METHODS
Generation ofTransgenic Mice. The cosmid clone cosCEAl, encompass
ing the complete human CEA gene, has been described previously (14). A
33-kilobase AatII DNA fragment from cosCEA1 containing the CEA gene as
well as 0.6 kilobase and 0.1 kilobase ofvector sequences at the 5'- and 3'-ends,
respectively, was isolated using the freeze-squeeze method (16). A solution
containing 2.5 ,.@g/mllevels of this fragment in 5 m@iTris, 0.1 m@iEDTA, pH
7.4, was used for microinjection into the male pronucleus of fertilized mouse
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oocytes derived from C57BL16 X CB6 F1 mice (Ciba Animal Breeding Center,
Basel, Switzerland), as described (17). Lines were established from founder
animals by mating with C57BL16 mice. Transgenic mice were identified either
by Southern blot analysis of tail DNA or by analysis of fecal extract (see
below).
Southern Blot Analyses. Tail DNA was isolated as described previously
(17). Standard Southern blot analysis was performed (18), using EcoRI
digested 32P-labeled cosCEAl as a probe. The probe was random-primed with
the Megaprime kit (Amersham-Buchler, Braunschweig, Germany). Final
washings were carried out at 66Â°Cin 0.1X SSPE, 0.1% sodium dodecyl sulfate
(1X SSPE is 0.18 M NaCl, 10 m@ sodium phosphate, pH 7.4, 1 m@iEDTA).
Under these conditions no cross-hybridization occurred beween the Alu dc
ments present in the probe and mouse repetitive sequences. For determination
of transgene copy number, 10 @gof mouse tail DNA were digested with Sac!
and hybridized in a standard Southern blot with a 32P-labeled4.8-kilobase Sac!
DNA fragmentof cosCEAl (see Fig. 1, bottom)anda 32P-labeled2.2-kilobase
EcoRI-SacI DNA fragment from a genomic clone (jMT1) containing the
mouse Thy-i gene, and the filters were washed under stringent conditions as
described above. The hybridization signals were quantified using a Bio
Imaging BAS1000 analyzer (Fuji, Tokyo, Japan). The number of CEA gene
copies was calculated by comparing the signal strength obtained with the CEA
probe with that of the single-copy Thy-i gene (19).
RNA Isolation and Detection. Total cellular RNA was isolated from
organs (either fresh or frozen at â€”70Â°C)according to the method of Chom
czynski and Sacchi (20). Standard Northern blot hybridization procedures were
performed (18). As a probe, the CEA cDNA insert lacking the 3'-untranslated
region (21) was excised with HindIII from plasmid pBEHCEA (22) and
radiolabeled as described above. Hybridizations were also carried out using a
32P-labeledmouse @3-actincDNA (23) to ascertain the intactness of the RNA.
Filters were washed under stringent conditions as described above.
Immunohistochemlcal Analyses. Organs isolated from adult mice (2-12
months of age), which had been anesthetized with Forene (Abbott GmbH,
Wiesbaden, Germany) and killed by cervical dislocation, either were frozen
immediately in isopentane at â€”70Â°Cand embedded in Jung freeze medium
(Leica Instruments, Nu@loch, Germany) diluted with 2 volumes of water or
were first fixed in 4% (w/v) paraformaldehyde in PBS at 4Â°Cfor 24â€”48h and
then incubated for 24 h in 0.5 M sucrose in PBS at 4Â°C.Cryostat sections
(6â€”7-g.irnthick) of tissues were fixed in acetone for 10 min at room temper
ature. Endogenous peroxidase activity was inhibited by first incubating sec
tions in methanol, 0.3% hydrogen peroxide, for 30 mm. The CEA-specific
chimeric mAb cT84.66 (24) was used either in complete form or as a Fab
fragment. Binding of the primary antibody was followed by incubation with
horseradish peroxidase-conjugated rabbit anti-human !gG (Dianova, Hamburg,
Germany). The staining reaction was performed using the substrate 3,3'-
diaminobenzidine tetrahydrochloride. Sections were counterstained with he
matoxylin.Stagedembryosandplacentaewere treatedlikewise. Earlierstage
embryos (embryonic days 8.5â€”12.5)were not dissected from the uterine tissue
but were sectioned in toto. Staged embryos (embryonic days 8.5â€”19.5)were
obtained from superovulated nontransgenic females fertilized by transgenic
males. Midday after vaginal plug formation was designated embryonic day 0.5.
Tissue Protein Extracts. Tissue from non-neoplastic regions of resected
colon from tumor patients (University Hospital, Freiburg, Germany) and
mouse colon tissue were pulverized under liquid N2 and resuspended in PBS,
0.5% Nonidet P-40, 2 mM phenyhnethylsulfonyl fluoride (1 mug frozen
tissue).The cells were lysedby ultrasonificationusinga BransonB-12 sonifier
(Heinemann, SchwÃ¤bisch-Gmllnd,Germany) with 5 pulses of 15 s each at 40
W. The homogenatewas centrifugedat 13,000 X g for 30 min at 4Â°Candthe
clear supernatantwas storedat â€”20Â°C.Proteinconcentrationwas determined
using the Bio-Rad (Munich, Germany) assay and bovine serum albumin
standards.
CEA Quantitation. Fecal pellets stored at â€”20Â°Cwere extracted by re
suspending the pellets in 2 volumes of PBS, 1% Triton X-100, incubating the
mixture for 5 min at room temperature, and saving the supernatant following
centrifugation at 13,000 X g for 10 mm at room temperature. The pellet was
reextracted with an equal volume of PBS, 1% Triton X-100, and the superna
tunIs were combined. Levels of CEA in extracts from mouse feces were
determined with a CPA EIA kit (Hoffmann LaRoche, Basle, Switzerland),
following the manufacturer'sinstructions.Determinationof the CEA content
in tissue extracts, human feces, and mouse serum was performedwith a
CPA-specific sandwich EUSA using combinations of the following mAbs:
Tet2, D14HD11, 26/3/13, and 26/5/1 (22).
RESULTS
Establishment of Mice Transgenic for the Human CEA Gene.
The CE4 transcription unit, flanked by 3.3 kilobases of 5'-sequence
and 5 kilobases of 3'-sequence, is contained within cosCEA1 (Fig. i)
(14). An AatII DNA fragment containing the insert from cosCEAi
was used to generate transgemc mice. Of the 36 mice born, i2 were
found to contain the human CEA gene. The Southern blot analysis of
nine animals is shown in Fig. i. Eight of these mice have intact copies
of the cosmid insert, since all expected fragments could be detected
(Fig. 1, top, compare lanes 1â€”8with lane 10). The presence of a
3.9-kilobase SstI DNA fragment in the different transgenic lines
indicates a preferential head-to.tail arrangement of the multiple insert
copies in tandem. The lack of this fragment and the presence of only
two end fragments in animal 2676 indicate the existence of only a
single-copy transgene (Fig. 1, top, !ane 2). No hybridization signals
were observed with DNA of a nontransgenic littermate (Fig. i, top,
Lane 9). Of the 12 mice which were found to be transgenic for human
CEA, eight transmitted this gene to their offspring. Four of these mice
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Fig.1. Identificationof transgenicmiceby Southernblotanalysis.Top,tail DNAof
founder animals (numbered at the top of each lane) was digested with SstI and subjected
to standard Southern blot analysis using 32P-labeled cosCEAl DNA as the probe.
Fragmentsizes are indicatedto the rightofthe blot. cosCEAi DNAwas also digested with
SstI and included as a positive control (lane 10). Note that vector sequences from
cosCEAi are contained within the 4.4-kilobase fragment and one of the 9.0-kilobase
fragments. The 3.9-kilobase fragment in lanes 1 and 3-8, which is the summation of the
2.2-kilobase and i.7-kilobase AatLI/SstI fragments (see bottom), reflects a head-to-tail
orientation of multiple transgene copies in tandem. Note more weakly hybridizing DNA
fragments, which probably contain cosmid end fragments and flanking mouse genomic
DNA sequences.Bottom,the SstI restrictionenzyme map of theAatII DNA fragmentof
cosCEAi is shown. Numbers, size of the fragments (in kilobases). Black boxes, exons.
Stri@box, potential 3'-exon. 5', 5'-noncoding region;L,leader;N, N (!gV-like)-domain;
Ai-3 and B1-3, IgC-like domain of subtypes A and B; M, membrane domain; 3',
3'-noncoding region. Open boxes, vector sequences. â€˜NCA',nonspecific cross-reacting
antigen-like;5, SStI.
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Fig. 2. Expression of human CEA mRNA in transgenic mice. A, 10 ,.&gof total RNA from a human and a nontransgenic mouse colon, along with various organs from three different
transgenic mice (mice 72, 65, and 62 from line 2683), were electrophoresed in a formaldehyde-agarose gel and transferred to a nylon membrane. The RNAs were hybridized with a
32P-labeledprobe covering the full-length CEA cDNA. The sizes ofthe CEA transcripts are indicated to the left ofthe blot. In the right margin, the positions ofthe 28S and i8S rRNAs
are shown. B, longer exposure of A. C, after decay of the CEA probe, the blot was rehybridized with a mouse @-actinprobe.
(mice 2681, 2682, 2683, and 2694) were used to establish independent
lines transgenic for CE4 and were analyzed in detail.
Analysis of CEA Expression at the mRNA and Protein Levels.
Northern blot analysis of RNA isolated from different organs of
transgenic mice revealed that CEA was not ubiquitously expressed
(Fig. 2). There are two CEA mRNA species in normal human colon
(Fig. 2A, lane 1), a 3.1-kilobase transcript and a less abundant
3.7-kilobase transcript, due to alternate polyadenylation (25). Both
products were also found in the tranagenic mice, indicating that the
transgene is being transcribed correctly. The expression pattern was
foundtobeessentiallyidenticalforthefourindependentlyestablished
lines transgenic for CEA. High levels of CEA mRNA were found in
colon and cecum (Fig. 2A, lanes 9 and 10), whereas lower levels were
present in stomach and small intestine (Fig. 2A, lanes 7 and 8). In
addition, very low levels were found in the lung, trachea, testis, and
esophagus (Fig. 28, lanes 4 and 14â€”16)but not in any other organ
tested (Fig. 2, A and B; see Table 2). Although not visible in Fig. 2,
after an extended exposure marginal hybridization signals were also
observed with uterus RNA. No hybridization signal was obtained with
RNA from the colon of a nontransgenic mouse (Fig. 2.4, lane 22).
The steady state levels of CEA mRNA in the colons of the four
different lines were compared with each other and with those of two
human colons in Northern blot analyses (Fig. 3). Although equal
amounts of RNA were loaded, variability in the levels between
transgenic lines was obvious. Compared with human colon, the
mRNA levels were lower in lines 2681 (mouse 301 1) and 2683
(mouse 3061) and approximately equal or slightly higher in lines 2682
(mouse3004)and2694(mouse3077).Theseexpressionlevelsdidnot
correlate with the transgene copy numbers of the different lines (Table
1). An additional CEA mRNA species that comigrated with the 28S
rRNA was seen in mouse 3077, but this was not further investigated.
The steady state protein levels in the feces, serum, and colon of
transgenic mice have been determined using a CEA EIA and CEA
ELISA and compared with the amounts found in humans (Table 1).
These protein levels were approximately 10 times higher for trans
genic line 2683 and 20 times higher for line 2682 in serum, and 2
times and 4 times higher, respectively, in feces, compared to the
normal human values. CEA levels in mice colon extracts were also
elevated, compared to normal human values. The sizes of the CEA
protein extracted from mouse and human colon were compared by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, whereby
CEA from mouse tissue (Mr 160,000) was smaller than CEA from
human colonic tissue (Mr@ 210,000). We are presently investigating
the reasons for this size discrepancy, which could possibly be due to
differences in glycosylation.
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Fig. 3. Northern blot analysis of CEA expression in colons of different transgenic lines.
Top, 10 @.tgof total RNA from colons of a nontransgenicmouse and two humans and total
colonic RNA from transgenic mouse lines 2694 (mouse 3077), 2681 (mouse 3011), 2683
(mouse 3061), and 2682 (mouse 3004) were hybridized with a 32P-labeled probe con
mining the full-length CEA cDNA. The sizes of the CEA transcripts are indicated to the
left of the blot. In the right margin, the positions of the 28S and 18S rRNAs are shown.
Bottom, after decay of the CEA probe the blot was rehybridized with a mouse @-actin
probe.
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Table 1 CEA concentration in colonictissue, ftce@, and serum ofmicetransgenicfor CEA, compared tohumansTransgene
copy number/CEA
concentrationaColonic
tissueFecesSpeciesStrainhaploid
genomea(ng/mg of total protein)(ng/mg of total protein)Serum(ng/ml)Mouse2681
2682
2683
26942.6
Â±0.2(n 2)
1.6 Â±0.2(n = 5)
5.6Â±O.6(n4)
8.5Â±i.2(n=4)NDâ€•
i,350@
1,800d
ND57,200
Â±19,lOO(n = 9)
28,400Â±l0,600(i@=5)
ND30.5
Â±12.7 (a = 6)
14.0Â±4.4 (n9)
NDNAe108
Â±38 (a = 2)13,800Â± i2,400(n 9)i.5@'
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Human
a M@ Â±SD.
b@ determined.
C Colon extracts from three mice were pooled.
d Colon extract from one mouse.
a NA, not applicable.
@â€˜Valuetak nfrom the literature.
corresponds to embryonic day 14 of mouse development (34), where
CEA can first be detected in the embryos of CE4-transgenic mice.
The transgene copy number and the CEA mRNA steady state levels
in the colons of four transgemc lines analyzed in Fig. 3 do not closely
correlate with the higher CEA steady state levels found in the colonic
extracts, feces, and serum of these transgenic mice, compared to
humans (Table 1). This indicates different post-translational regula
tion mechanisms or longer CEA turnover rates in the transgenic mice
than in humans.
CEA is not expressed during early embryonic development in either
humans or transgenic mice. In these mice, it first appears in the
trophoblast giant cells of the placenta from embryonic day 10.5 until
embryonic day 16.5, which correlates with a recent report of CEA in
human syncytiotrophoblast cells (35). The primitive gut of mice
develops around embryonic day 8, but CEA is first definitively found
in the developing gut at embryonic day 14.5, so that it cannot play a
role in organogenesis, as reported for other cell adhesion molecules,
e.g., cadherins(36); however,it couldplay a role in the conversionof
the multilayered embryonic intestinal epitheia into the single-epithe
hal cell layer lining the mature gut. Interestingly, mouse BGP1
(former name, mmCGM1/2), which possibly represents the mouse
CEA analogue, has a similar late onset of expression during embry
ogenesis in the intestine (37).
In spite of the relatively high levels of CEA in some of the transgenic
mouse strains, no obvious phenotypic differences have been observed in
comparison to their nontransgemc siblings. Similar results were observed
for CEA-transgethcmice that ubiquitouslyexpress CFA under the control
of the simian virus 40 early promoter (38).
The expression pattern of the transgene reported here implies that
all regulatory elements for correct spatiotemporal expression are pre
sent in the human genomic DNA fragment used to generate the
transgenic mice and that they are correctly recognized by murine
traM-acting factors. This is especially noteworthy because no mouse
CEA gene has yet been discovered, despite intensive searches. This
suggests that the regulatory elements and transcription factors are
strongly conserved during evolution. Furthermore, since the four
mouse strains analyzed show identical expression patterns, the trans
gene activity is independent of the site of integration. This indicates
the presence of sequences in the transferred human genomic DNA
fragment which shield the CEA gene from the influences of regulatory
elements close to the sites of transgene insertion.
Because the CEA transgene is mainly expressed in epithelial cells
of the gastrointestinal tract, its regulatory elements could be valuable
for studying tumorigenesis in vivo. These epitheial cells have an
extremely rapid cellular turnover and are continuously regenerated
from a multipotent stem cell in each crypt (reviewed in Ref. 39). In the
colon they migrate from the base of the crypt to a hexagonally shaped
4172
Immunohistochemical Analysis of CEA Expression in Adult
Mice. We analyzed various mouse organs in the different lines (2682
and 2683 were studied in detail) by immunohistochemistry using the
chimeric mAb cT84.66, to investigate in which tissues CEA is pro
duced. As well as being specific for CEA, mAb cT84.66 has the
additional advantage that endogenous mouse immunoglobulins do not
interfere with immunostaining, because anti-human immunoglobulin
antibodies can be used to detect the primary antibody. In mice
transgenic for CEA, we detected CEA in those organs which cx
pressed its RNA. In nontransgenic littermates, no staining was seen in
any organs, as exemplified for colon (Fig. 4B). We found CEA in the
epithelial cells along the crypts of transgenic mouse colon but it did
not seem to be confmed to the apical surface as in humans (Fig. 4A).
Furthermore, CEA was present in the crypts but not in the villi of the
small intestine (Fig. 4C), in the superficial zone of the gastric mucosa
(Fig. 4D), on the squamous epithelial cells of the esophagus (Fig. 4E),
and in the papillae filiformae of the tongue (Fig. 4F). In addition to
the expression of CEA along the gastrointestinal tract, CEA was found
in squamous epitheial cells of the trachea (Fig. 4G) and alveoli of the
lung (Fig. 4H). No staining was seen in the liver (Fig. 4!) or various
other organs (Table 2).
Immunohistochemical Analysis of CEA Expression During
Mouse Development. We have analyzed the expression of CEA
during mouse development, at embryonic days 8.5, 10.5, 12.5, 14.5,
16.5, and 19.5. CEA was first seen at embryonic day 10.5 in the
primary trophoblast giant cells of the placenta that are in direct contact
with the maternal decidua (Fig. 5, A and B). After embryonic day
16.5, CEA was no longer found in the placenta, which correlates with
the disappearance of these giant cells (26). CEA could not be detected
within the embryo until embryonic day 14.5, when the developing gut,
trachea, lung, urethra, and nucleus pulposus of the vertebral column
stained weakly. A stronger staining of these organs was found during
progression of development (Fig. 5, C-H). CEA was also seen in
squamous epithelia of the tongue and the nasal mucosa from embry
onic day 16.5 onwards. All of these data are summarized in Table 2.
DISCUSSION
The spatiotemporal expression pattern of the human CE4 gene in
animals of the different mouse lines analyzed is essentially identical to
that observed in humans. CEA gene expression has been reported in
humans, at either the mRNA or protein level, in the colon, small
intestine, stomach, esophagus, tongue, lung, testis, and cervix (11,
27â€”33).Tissues and organs that are CEA-negative in humans, e.g.,
liver, kidney, salivary glands, and pancreas, are also negative in
transgenic animals (11, 30). During human embryogenesis, CEA is
first seen around the eighth week of development (1, 27, 28). This
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Fig. 4. Immunohistochemicalanalysesof humanCEA in adultmice. Cryostatsections of organsfrom lines 2682, 2683, and 2694 were stainedwith the chimericanti-CEAmAb
1'84.66 using the indirect peroxidase method. Similar staining patterns were obtained with all three transgenic lines. A, colon of transgenic mouse 3820 (line 2682); note apical staining
of enterocytes(lowerleft);B, colonfroma nontransgenicmouse;C, smallintestinefromtransgenicmouse3007(line2682);D, glandularregionof thestomach(mouse3079,line
2694); E, esophagus (mouse 128, line 2682); F, tongue (mouse 3007, line 2682); G, trachea (mouse 124, line 2683); H, lung (mouse 128, line 2682); 1, liver (mouse 3079, line 2694).
a!, alveolae;Ca,cartilage;Cr,crypt;dz, deepzoneof gastricfoveolae;1,lumen;Ip, laminapropria;mm,muscularismucosae;pf, papillaefiliformes;se, squamousepithelium;sm,
submucosa; ax, superficial zone of gastric foveolae; v, villus. Horizontal bar, 100 bun.
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Fig. 5. ImmUnOhistOChemicalanalyses ofhuman CEA daring mouse embryogenesis. Cryastat sections ofembryos (line 2683)were stained with the chimeric anti-CPA math T84.66 using
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ofthe region indicatedmA, showingstainingof a giant cell in closecontactwith maternaldeciduacells C, sagittalsectionofa wholeembryoat embiyonicday 16.5;D, vertebraewith nucleus
pulposus stained in an embryonic day 16$ embryo; E, lung from an embryo(embryonic day 193) with stained bronchiolar epithelium F, sagittal section ofa whole embryo at embryonic day
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CE.4GENE EXPRESSIONIN TRAN5GENIC MICE
a@ although some of the organs cannot be distinguished at these stages of devel
opment,no stainingwhatsoeverwas seen within the embryo.
b ND, not determined.
CNA, not applicable.
cuff of surface epitheial cells and are subsequently exfoliated into the
intestinal lumen. Since CEA protein is found down to the base of the
crypts in the colon of the transgenic animals, the CEA gene is possibly
active in the self-renewing and positionally fixed crypt stem cells. If
this is the case, the CEA promoter could be used to direct expression
of activated oncogenes or dominant negative mutants of tumor sup
pressor genes to intestinal stem cells, to study the genetic events
during intestinal tumorigenesis. A similar approach has been at
tempted using the intestinal fatty acid-binding protein gene promoter
to drive the expression of various oncogenes in the intestine. How
ever, while dysplastic changes did occur, no tumor formation was
observed in that system, which was probably due to the lack of
promoter activity in the stem cells and the rapid exfoliation of the
epithelial cells (40).
Finally, the CE4-transgenic mice offer an animal model system for
optimizing tumor immunotherapy prior to clinical trials using CEA as
a target antigen. To achieve this, adenomas or adenocarcinomas must
first be induced in these transgenic animals, either chemically or by
breeding with tumor-prone mice. If these tumors express CEA, this
system would have a number of advantages over currently available
animal models, e.g., human tumors transplanted into athymic nude
mice (41) or mice inoculated with syngeneic tumor cells transfected
with a CEA cDNA (42). Firstly, the expression of CEA in normal
tissues will allow investigations into the possible negative side effects
of both active and passive immunotherapy. Secondly, CE4-transgenic
animals are fully inimunocompetent, in contrast to athymic nude
mice. Thirdly, the induced CEA-expressing tumors have an authentic
location, which would mirror the human situation more closely.
Fourthly, assuming tolerance to CEA in these transgenic mice, this
system may be used to optimize immunolocalization of tumors with
CEA as a target antigen, since no masking of the xenoantigen by
induced antibodies should occur. This has been a problem with the
syngeneic transfectant approach (21). Although these transgenic mice
exhibit relatively high serum levels of CEA, compared to healthy
humans (Table 1), this should not be a problem for targeting tumors,
because even very high CEA serum concentrations (500 ng/ml) do not
prevent effective homing of anti-CEA antibodies through complex
formation (43).
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